Medicines for Europe letter to EC on Divisionals & Patent Linkage re Fingolimod – 13.04.2022

3 May 2022

Policy

Note on Transferable Vouchers – April 2022

22 April 2022

Policy

Position Paper – Unitary SPC & Unified Mechanism for the Granting of SPCs

1 April 2022

Policy

Policy recommendations on uptake of biosimilar medicines in the retail market

5 November 2021

Policy

Policy recommendations on uptake of biosimilar medicines in the retail […]

Positioning Statements on Physician-led Switching for Biosimilar Medicines

1 October 2021

Policy

Positioning statements on physician-led switching for biosimilar medicines (October 2021) […]

Position Paper. Incentives Review The Orphan and Paediatric Incentives

1 March 2021

Policy

Second wave pandemic preparedness: procurement principles

24 August 2020

Policy

Policy Roadmap for Medicines Manufacturing Leadership

6 July 2020

Policy

Call for tenders SANTE/2020/C3/29 for the supply of medicinal products used for intensive care patients subject to the novel coronavirus (COVID-19) disease – policy and technical concerns

25 June 2020

Policy

Preparing for a potential second COVID-19 wave. Joint statement by Medicines for Europe and EFPIA with Kearney

22 June 2020

Policy